Comprehensive review of uterine leiomyosarcoma: pathogenesis, diagnosis, prognosis, and targeted therapy

Q Yang, OS Madueke-Laveaux, H Cun, M Wlodarczyk… - Cells, 2024 - mdpi.com
Uterine leiomyosarcoma (uLMS) is the most common subtype of uterine sarcomas. They
have a poor prognosis with high rates of recurrence and metastasis. The five-year survival …

Molecular insights in uterine leiomyosarcoma: a systematic review

R Sparić, M Andjić, I Babović, L Nejković… - International Journal of …, 2022 - mdpi.com
Uterine fibroids (UFs) are the most common benign tumors of female genital diseases,
unlike uterine leiomyosarcoma (LMS), a rare and aggressive uterine cancer. This narrative …

Gene expression signatures of primary and metastatic uterine leiomyosarcoma

B Davidson, VM Abeler, M Førsund, A Holth, Y Yang… - Human pathology, 2014 - Elsevier
Leiomyosarcoma (LMS) is the most common uterine sarcoma. Although the disease is
relatively rare, it is responsible for considerable mortality due to frequent metastasis and …

Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma

Q Zhang, J Ubago, L Li, H Guo, Y Liu, W Qiang… - Cancer, 2014 - Wiley Online Library
BACKGROUND Uterine smooth muscle tumors (USMTs) constitute a group of histologic,
genetic, and clinical heterogeneous tumors that include at least 6 major histologically …

Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways

T Cuppens, M Moisse, J Depreeuw… - … journal of cancer, 2018 - Wiley Online Library
Uterine leiomyosarcomas (uLMS) are rare, aggressive malignancies for which limited
treatment options are available. To gain novel molecular insights into uLMS and identify …

[HTML][HTML] Uterine smooth muscle tumor analysis by comparative genomic hybridization: a useful diagnostic tool in challenging lesions

S Croce, A Ribeiro, C Brulard, JC Noel, F Amant… - Modern Pathology, 2015 - Elsevier
The diagnosis and management of uterine smooth muscle tumors with uncertain malignant
potential (STUMP) is often challenging, and genomic data on these lesions as well as on …

MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors

KE Schwetye, JD Pfeifer, EJ Duncavage - Human pathology, 2014 - Elsevier
Mutations in exon 2 of the MED12 gene have been reported in 50% to 70% of uterine
leiomyomas. To determine the frequency of MED12 mutations in various types of smooth …

[HTML][HTML] Central role of CEMIP in tumorigenesis and its potential as therapeutic target

L Li, LH Yan, S Manoj, Y Li, L Lu - Journal of Cancer, 2017 - ncbi.nlm.nih.gov
CEMIP (KIAA1199) was identified as migratory indicator protein which had been crudely
studied in the last decade. Firstly its mutation site was reported to cause hearing loss due to …

[HTML][HTML] The biology and treatment of leiomyosarcomas

WGJ Kerrison, K Thway, RL Jones… - Critical Reviews in …, 2023 - Elsevier
Leiomyosarcoma (LMS) is a soft tissue sarcoma of smooth muscle origin that can arise in
multiple anatomical sites and is broadly classified as extra-uterine LMS or uterine LMS …

[HTML][HTML] microRNA-18b is upregulated in breast cancer and modulates genes involved in cell migration

MA Fonseca-Sanchéz… - Oncology …, 2013 - spandidos-publications.com
Abstract microRNAs are small non-coding RNAs of~ 22 nucleotides that function at post-
transcriptional level as negative regulators of gene expression. Aberrant expression of …